Phase II Study of the Hyper-CVAD Regimen in Sequential Combination With Blinatumomab With or Without Inotuzumab Ozogamicin as Frontline Therapy for Adults With B-Cell Lineage Acute Lymphocytic Leukemia
Latest Information Update: 22 May 2024
At a glance
- Drugs Blinatumomab (Primary) ; Cyclophosphamide; Cytarabine; Cytarabine; Dexamethasone; Dexamethasone; Doxorubicin; Filgrastim; Folinic acid; Mercaptopurine; Mesna; Methotrexate; Ofatumumab; Pegfilgrastim; Prednisone; Rituximab; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 17 May 2024 Status changed from active, no longer recruiting to recruiting.
- 10 May 2024 Status changed from recruiting to active, no longer recruiting.
- 21 Sep 2023 Planned End Date changed from 1 Nov 2023 to 1 Nov 2026.